Fast Track Designation is a process designed by the FDA to expedite the review of drugs and therapies that treat serious conditions and fill an unmet medical need. This designation aims to get important new drugs to patients earlier. In the context of epidemiology, this can be crucial in managing outbreaks, controlling the spread of diseases, and addressing urgent public health needs.
